These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 15194556

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Successful treatment with a rituximab-based regimen of a splenic marginal zone lymphoma with villous lymphocytes in a very frail patient on maintenance dialysis.
    Niscola P, Palumbo R, Scaramucci L, Tendas A, Cupelli L, Giovannini M, Piccioni D, Dentamaro T, Perrotti AP, de Fabritiis P.
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):759-60. PubMed ID: 18500519
    [No Abstract] [Full Text] [Related]

  • 23. Hyperacute pulmonary edema complicating rituximab infusion.
    Chan KH, Ng MK.
    Eur J Intern Med; 2009 Jan; 20(1):e13. PubMed ID: 19237066
    [No Abstract] [Full Text] [Related]

  • 24. Intraocular rituximab.
    Singh AD, Peereboom DM.
    Eye (Lond); 2007 Dec; 21(12):1453-4. PubMed ID: 18159211
    [No Abstract] [Full Text] [Related]

  • 25. [Pulmonary MALT lymphoma with macroglobulinemia].
    Takasaki H, Takabayashi M, Yamaji S, Koharazawa H, Fujimaki K, Kanamori H, Ishigatsubo Y.
    Rinsho Ketsueki; 2005 Feb; 46(2):144-6. PubMed ID: 16447709
    [Abstract] [Full Text] [Related]

  • 26. Treatment of primary intraocular lymphoma (PIOL) has involved systemic, intravitreal or intrathecal chemotherapy and/or radiotherapy.
    Itty S, Olson JH, O'Connell DJ, Pulido JS.
    Retina; 2009 Mar; 29(3):415-6. PubMed ID: 19174721
    [No Abstract] [Full Text] [Related]

  • 27. Long-term safety and activity of cladribine in patients with extranodal B-cell marginal zone lymphoma of the mucosa-associated lymphoid tissue (MALT) lymphoma.
    Kiesewetter B, Dolak W, Simonitsch-Klupp I, Mayerhoefer ME, Raderer M.
    Hematol Oncol; 2017 Jun; 35(2):177-186. PubMed ID: 26580149
    [Abstract] [Full Text] [Related]

  • 28. Transformation of MALT lymphoma to pure plasma cell histology: possible association with anti-CD20 antibody treatment.
    Klein N, Elis A, Radnay J, Zemer R, Klein A, Lishner M.
    Isr Med Assoc J; 2009 Nov; 11(11):703-4. PubMed ID: 20108563
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma.
    Raderer M, Wohrer S, Streubel B, Drach J, Jager U, Turetschek K, Troch M, Puspok A, Zielinski CC, Chott A.
    Oncology; 2006 Nov; 70(6):411-7. PubMed ID: 17220639
    [Abstract] [Full Text] [Related]

  • 31. Persistent panhypogammaglobulinemia after CHOP-rituximab for HIV-related lymphoma.
    Miles SA, McGratten M.
    J Clin Oncol; 2005 Jan 01; 23(1):247-8. PubMed ID: 15625386
    [No Abstract] [Full Text] [Related]

  • 32. Rapid infusion of rituximab over 60 min.
    Tuthill M, Crook T, Corbet T, King J, Webb A.
    Eur J Haematol; 2009 Apr 01; 82(4):322-5. PubMed ID: 19220420
    [Abstract] [Full Text] [Related]

  • 33. Successful rituximab monotherapy for API2-MALT1 fusion positive primary mucosa-associated lymphoid tissue lymphoma of the transverse colon in a patient with liver cirrhosis.
    Yamada M, Kawahara H, Shiroeda H, Tsuchishima M, Masaki Y, Sato K, Takase S.
    Scand J Gastroenterol; 2008 Apr 01; 43(6):761-4. PubMed ID: 18569996
    [No Abstract] [Full Text] [Related]

  • 34. Persistent residual disease in t(11;18)(q21;q21) positive gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy or rituximab.
    Salar A, Bellosillo B, Serrano S, Besses C.
    J Clin Oncol; 2005 Oct 10; 23(29):7361-2; author reply 7362-3. PubMed ID: 16210674
    [No Abstract] [Full Text] [Related]

  • 35. Conjunctival malt lymphoma successfully treated with single agent rituximab therapy.
    Salepci T, Seker M, Kurnaz E, Guler DO, Bilici A, Dane F, Aliustaoglu M, Atesoglu EB, Gumus M, Yaylaci M.
    Leuk Res; 2009 Mar 10; 33(3):e10-3. PubMed ID: 18653234
    [No Abstract] [Full Text] [Related]

  • 36. Extended rituximab schedules may result in increased efficacy in pulmonary malt lymphoma.
    Seker M, Bilici A, Ustaalioglu BO, Salman T, Sonmez B, Canpolat NA, Salepci T, Gumus M, Yaylaci M.
    Leuk Res; 2009 Sep 10; 33(9):e154-6. PubMed ID: 19386361
    [No Abstract] [Full Text] [Related]

  • 37. Somatostatin receptor scintigraphy in MALT lymphoma of the lacrimal gland treated with rituximab.
    Morgensztern D, Rosado MF, Serafini AN, Lossos IS.
    Leuk Lymphoma; 2004 Jun 10; 45(6):1275-8. PubMed ID: 15360012
    [Abstract] [Full Text] [Related]

  • 38. [Primary mucosa-associated lymphoid tissue lymphoma of the urinary bladder successfully treated by radiotherapy and rituximab].
    Terasaki Y, Okumura H, Ishiura Y, Yokawa S, Kuribayashi M, Kodama K, Motoi I, Sugihara M, Saito K, Tanaka T, Yoshino T, Ohtake S, Nakao S.
    Rinsho Ketsueki; 2008 Jan 10; 49(1):30-4. PubMed ID: 18277593
    [Abstract] [Full Text] [Related]

  • 39. [Combination of rituximab with combined pulse-therapy with high doses of methylprednisolone and cyclophosphamide: effects on immunomorphological and functional disturbances of the salivary glands in a patient with Sjogren's disease and MALT-lymphoma].
    Vasil'ev VI, Kokosadze NV, Logvinenko OA, Nikitin EA, Mitrikov BV, Rodionova EB, Varlamova EIu.
    Ter Arkh; 2008 Jan 10; 80(5):76-9. PubMed ID: 18590121
    [No Abstract] [Full Text] [Related]

  • 40. Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases.
    Kerl K, Prins C, Saurat JH, French LE.
    Br J Dermatol; 2006 Dec 10; 155(6):1197-200. PubMed ID: 17107389
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.